EXOZ

EXOZYMES INC. SEC filings

Every EDGAR filing for EXOZYMES INC. (EXOZ), newest first, with AI summaries and stories.

Ticker: EXOZ
CIK: 2010788
Sector: Biotech and pharma
Latest filing: Oct 9

Next: 10-Q expected ~Nov 13 (deadline Nov 16)

Watch in the app Get the app

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

ROUTINE8-KEXOZYMES INC.EXOZOct 9
EXOZYMES INC files 8-K
- Filed on 2026-10-09
- Investor presentation dated 2026-10-06
- Registered on Nasdaq
Company Filing
ROUTINEDEF 14AEXOZYMES INC.EXOZSep 28
Proxy statement
Company Filing
ROUTINEDEFA14AEXOZYMES INC.EXOZSep 28
Additional proxy materials
Company Filing
ROUTINE8-KEXOZYMES INC.EXOZSep 18
Current report
Company Filing
ROUTINE4EXOZYMES INC.EXOZSep 17
Fouad Nawaz, insider filing for EXOZ
Company Filing
Fouad Nawaz, reporting
ROUTINE4EXOZYMES INC.EXOZSep 2
Michael Heltzen, insider filing for EXOZ
Company Filing
Michael Heltzen, reporting
ROUTINE4EXOZYMES INC.EXOZAug 25
2 insider filings
Damien Alan Perriman, insider filing for EXOZ
Show all 2
- 4Insider filing for EXOZAug 25
- 4Insider filing for EXOZAug 25
Damien Alan Perriman, reporting
NOTABLE10-QEXOZYMES INC.EXOZAug 13
Quarterly report
Company Filing
ROUTINE8-KEXOZYMES INC.EXOZJul 1
Current report
Company Filing
ROUTINE424B5EXOZYMES INC.EXOZJun 30
Securities offering
Company Filing
ROUTINE8-KEXOZYMES INC.EXOZJun 26
Current report
Company Filing
ROUTINE8-KEXOZYMES INC.EXOZJun 17
Current report
Company Filing
ROUTINE8-KEXOZYMES INC.EXOZJun 8
Current report
Company Filing
ROUTINE424B5EXOZYMES INC.EXOZJun 8
Securities offering
Company Filing
ROUTINE424B5EXOZYMES INC.EXOZJun 4
Securities offering
Company Filing
ROUTINE424B5EXOZYMES INC.EXOZMay 29
Securities offering
Company Filing
NOTABLE10-QEXOZYMES INC.EXOZMay 14
Quarterly report
Company Filing
ROUTINE8-KEXOZYMES INC.EXOZMay 7
Current report
Company Filing
ROUTINE8-KEXOZYMES INC.EXOZApr 10
Current report
Company Filing
ROUTINE4EXOZYMES INC.EXOZApr 10
Tyler Paz Korman, insider filing for EXOZ
Company Filing
Tyler Paz Korman, reporting
ROUTINE424B5EXOZYMES INC.EXOZApr 9
Securities offering
Company Filing
ROUTINE4EXOZYMES INC.EXOZApr 8
2 insider filings
Damien Alan Perriman, insider filing for EXOZ
Show all 2
- 4Insider filing for EXOZApr 8
- 3New insider at EXOZApr 8
Damien Alan Perriman, reporting
ROUTINE4EXOZYMES INC.EXOZApr 8
4 insider filings
Damien Alan Perriman, insider filing for EXOZ
Show all 4
- 4Insider filing for EXOZApr 8
- 4Insider filing for EXOZApr 8
- 4Insider filing for EXOZApr 8
- 4Insider filing for EXOZApr 8
Damien Alan Perriman, reporting
ROUTINE8-KEXOZYMES INC.EXOZMar 31
Current report
Company Filing
NOTABLE10-KEXOZYMES INC.EXOZMar 30
Annual report
Company Filing
ROUTINE8-KEXOZYMES INC.EXOZFeb 5
Current report
Company Filing
ROUTINE424B2EXOZYMES INC.EXOZJan 26
Securities offering
Company Filing
ROUTINEEFFECTEXOZYMES INC.EXOZJan 26
Registration declared effective
Company Filing
ROUTINES-3EXOZYMES INC.EXOZJan 16
Securities offering
Company Filing
ROUTINES-8EXOZYMES INC.EXOZDec 16, 2025
Employee stock plan registration
Company Filing
MAJOR8-KEXOZYMES INC.EXOZNov 13, 2025
EXOZYMES INC. (EXOZ) announced the resignation of its CEO, effective immediately, citing strategic differences with the Board of Directors. This unexpected leadership change introduces uncertainty around the company's near-term direction and execution of its core enzyme…
Company Filing
NOTABLE10-QEXOZYMES INC.EXOZNov 13, 2025
EXOZYMES INC. (EXOZ) filed its Q3 2025 quarterly report (Form 10-Q), providing investors an update on the company's financial performance and operational activities.
Company Filing

Older filings on EDGAR

Get an email when EXOZYMES INC. files

Filings

EXOZYMES INC files 8-K

2 insider filings

2 insider filings

4 insider filings

EXOZYMES INC. (EXOZ) announced the resignation of its CEO, effective immediately, citing strategic differences with the Board of Directors. This unexpected leadership change introduces uncertainty around the company's near-term direction and execution of its core enzyme…

EXOZYMES INC. (EXOZ) filed its Q3 2025 quarterly report (Form 10-Q), providing investors an update on the company's financial performance and operational activities.